UBS Group
CIM

UBS Group’s Chimera Investment CIM Stock Holding History

UBS Group’s Portfolio CIM Stock Details CIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50,000
Closed -$1.44M – 8020
2020
Q2 		$1.44M Sell
50,000
-116,667
-70% -$3M ﹤0.01% 3184
2020
Q1 		$4.55M Buy
+166,667
New +$9.46M ﹤0.01% 2010

Other funds holding CIM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $10.5B AUM 30.38% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

UBS Group's CIM Position: Q2 2026 in Review

UBS Group reduced its Chimera Investment (CIM) stake by 7.7% in Q2 2026, selling an estimated $491K and leaving 440,890 shares worth $5.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3992.

UBS Group first reported a position in CIM in Q4 2014 and has held it in 47 quarters since. The position peaked at $57.3M in Q3 2019. 197 funds tracked by Wall St. Rank hold CIM as of Q2 2026.

  • UBS Group held 440,890 shares of Chimera Investment worth $5.88M as of Q2 2026.
  • UBS Group sold 36,709 Chimera Investment shares in Q2 2026, an estimated $491K.
  • Chimera Investment made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3992 holding.
  • UBS Group first reported a position in Chimera Investment in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Chimera Investment position peaked at $57.3M in Q3 2019.
  • 197 funds tracked by Wall St. Rank held Chimera Investment as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.